CJC-1295 with DAC
Sourcing GuideSourcing CJC-1295 with DAC from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. A long-acting growth-hormone-releasing-hormone analogue with a Drug Affinity Complex that extends half-life to roughly a week. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.
Key Takeaways
Procurement lens: CJC-1295 with DAC sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching ~3367 Da. Mechanism: Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release. The maleimide-based Drug Affinity Complex (DAC) tail covalently binds serum albumin, extending half-life from minutes to days. Stimulates pulsatile GH secretion that elevates baseline IGF-1. Quality control discipline for CJC-1295 with DAC starts with mechanism understanding: which assays detect counterfeits, which impurities matter for the intended use, and which storage conditions preserve activity. The subsections work through HPLC purity, COA evaluation, reconstitution protocol, and vendor selection.
HPLC purity and analytical identity
Minimum acceptable HPLC purity for CJC-1295 with DAC is ≥98% in research-grade material. Mass spec confirmation should show the characteristic m/z of ~3367 (M+H)+. Contaminant peaks above 1% in the HPLC trace warrant quantification on the COA and — ideally — structural identification of the major impurities.
Vendor tier comparison and price discipline
Three vendor tiers operate in the CJC-1295 with DAC market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
Reconstitution and storage protocols
CJC-1295 with DAC is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
For users targeting red flag detection, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Pharmaceutical-grade compounded CJC-1295 with DAC is the lowest-risk sourcing path for bac water sourcing use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
Sourcing CJC-1295 with DAC for hplc purity use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
For users targeting pricing analysis, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 1-2 mg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 1-2 mg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 1-2 mg | 1-2x weekly |
| Maintenance phase | SubQ | 1-2 mg | Ongoing with periodic pauses |
Dose timing for CJC-1295 with DAC is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses. Fasted dosing produces stronger GH pulses; meal-paired dosing blunts the response.
CJC-1295 with DAC stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- CJC-1295 with DAC + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with CJC-1295 with DAC's mechanism in sourcing / quality / procurement protocols.
- CJC-1295 with DAC + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with CJC-1295 with DAC's mechanism in sourcing / quality / procurement protocols.
- CJC-1295 with DAC + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with CJC-1295 with DAC's mechanism in sourcing / quality / procurement protocols.
- CJC-1295 with DAC + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with CJC-1295 with DAC's mechanism in sourcing / quality / procurement protocols.
Sustained IGF-1 elevation; monitor in users at risk of malignancy. Site reactions, transient flushing, water retention possible.
Lens-specific safety considerations for sourcing / quality / procurement use of CJC-1295 with DAC: Sustained IGF-1 elevation; monitor in users at risk of malignancy. Site reactions, transient flushing, water retention possible. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| CJC-1295 with DAC | Long-acting GHRH analogue | ~6-8 days (with DAC) | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Visual quality inspection?
Pharmaceutical-grade versus research-grade?
Vendor red flags?
Storage protocol?
What are the procurement red flags for CJC-1295 with DAC?
What is the standard dosing protocol for CJC-1295 with DAC?
Start a CJC-1295 with DAC Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified CJC-1295 with DAC and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- ~3367 Da
- Sequence length
- 30 aa
- Half-life
- ~6-8 days (with DAC)
- WADA
- Banned (S2 class)
- FDA
- Unapproved
- Research
- Phase II human data; widely used off-label
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for CJC-1295 with DAC unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for CJC-1295 with DAC
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised